Programming angiogenesis with tunable assemblies of multifunctional peptides
Authors:
- Joseph Dodd-OJDJoseph Dodd-O
- Bobak ShadpoorBSBobak Shadpoor
- Abhishek RoyARAbhishek Roy
- Roya JafariRJRoya Jafari
- Abigail HolbertonAHAbigail Holberton
- Dongjing HeDHDongjing He
- Francesco CoppolaFCFrancesco Coppola
- Daniel M. DinakarapandianDDDaniel M. Dinakarapandian
- Deep MaluDMDeep Malu
- Alexandra GriffithAGAlexandra Griffith
- 31 July 2026
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (31)
Abstract
Therapeutic angiogenesis is constrained by the inability to localize, sustain, and finely tune vascular signaling. Here, we detail a supramolecular peptide system that enables angiogenic programming by decoupling mechanical integrity from receptor-level bioactivity. We integrate a vascular endothelial growth factor (VEGF)–mimetic amphiphile (SLan) with a mechanically robust β sheet peptide (K1) to yield injectable nanofiber hydrogels with tunable stiffness (100 to 1000 pascals) and preserved vascular endothelial growth factor receptor 2 (VEGFR2) affinity. Molecular dynamics simulations and solid-state nuclear magnetic resonance revealed that the coassembly mitigates steric interference between domains, enabling dense supramolecular packing while maintaining optimal receptor accessibility. The resulting SLan-K1 formulation preserves the secondary structure, activating canonical VEGFR2–MEK (mitogen-activated protein kinase kinase)–ERK (extracellular signal–regulated kinase). In vitro, these hydrogels induce endothelial proliferation; in vivo, they drive rapid neovascular infiltration and stable vascular integration in murine and rodent implants. This design unites peptide self-assembly, receptor binding kinetics, and immunophenotypic outcomes in defining a molecular framework for tunable angiogenic materials. This strategy establishes a modular platform for engineering instructive microenvironments that bridge molecular design and tissue-scale functionality.Keywords
Funding Information
- National Science Foundation (NSF DMR 2212123)
- NIH (NIDCR R01DE031812)
- NIH (RF1AG073434-01A1)
- NIH (OD S10OD026875-01A1)
This publication has 59 references indexed in Scilit:
- Angiogenic Hydrogels to Accelerate Early Wound HealingMacromolecular Bioscience, 2022
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)European Journal of Immunology, 2021
- Angiogenic hydrogels for dental pulp revascularizationActa Biomaterialia, 2021
- Extracellular signal‐regulated kinase regulates microglial immune responses in Alzheimer’s diseaseJournal of Neuroscience Research, 2021
- Comprehensive phenotyping of endothelial cells using flow cytometry 1: MurineCytometry Part A, 2020
- BioMagResBank (BMRB) as a Resource for Structural Biology2020
- Nanofibrous peptide hydrogel elicits angiogenesis and neurogenesis without drugs, proteins, or cellsBiomaterials, 2018
- Treatment of hind limb ischemia using angiogenic peptide nanofibersBiomaterials, 2016
- CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR dataJournal of Computational Chemistry, 2013
- CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fieldsJournal of Computational Chemistry, 2009